| Screening and treatment program to eliminate hepatitis C in Egypt I Waked, G Esmat, A Elsharkawy, M El-Serafy, W Abdel-Razek, R Ghalab, ... New England Journal of Medicine 382 (12), 1166-1174, 2020 | 229 | 2020 |
| Pregnancy outcome of anti‐HCV direct‐acting antivirals: Real‐life data from an Egyptian cohort M AbdAllah, M Alboraie, W Abdel‐Razek, M Hassany, I Ammar, E Kamal, ... Liver International 41 (7), 1494-1497, 2021 | 28 | 2021 |
| Treatment of hepatitis C virus infection with direct-acting antivirals plus ribavirin eliminates viral RNA from peripheral blood mononuclear cells and reduces virologic relapse … MDA Abd Alla, RM Dawood, HAELH Rashed, G Farrag, IAE Ammar, ... Archives of virology 166, 1071-1081, 2021 | 10 | 2021 |
| Nationwide hepatitis C virus screening and treatment of adolescents in Egyptian schools E Kamal, N Asem, M Hassany, G Elshishiney, W Abdel-Razek, H Said, ... The Lancet Gastroenterology & Hepatology 7 (7), 658-665, 2022 | 5 | 2022 |
| The world's largest hepatitis C screening program in Egypt W Abdel-Razek, M Hassany, K Kabil, I Ammar, H Dabous, W Doss, ... Journal of Hepatology 70, E144-E145, 2019 | 4 | 2019 |
| Utility of telemedicine in the treatment of patients with chronic HCV infection using DAAs in remote areas with limited resources. M Abd Allah, S Wahed, I Ammar, E Kamal, M Alboraie, W Abdel‐Razek, ... Liver International 41 (8), 2021 | 3 | 2021 |
| Evaluation of factors affecting patients’ refusal of HCV treatment in a cohort of Egyptian patients MB Hashem, HA Badary, NA Mahfouz, S Adel, M Alboraie, M AbdAllah, ... Journal of Public Health 45 (1), 214-217, 2023 | 2 | 2023 |
| Efficacy and safety of ombitasvir/paritaprevir/ritonavir-based therapy in HCV patients with chronic kidney disease M El-Sayed, M Elserafy, M El Raziky, W Elakel, Y Saad, T Fayad, ... Arab Journal of Gastroenterology 24 (1), 29-33, 2023 | 1 | 2023 |
| IL28B-Gene Polymorphisms (rs12979860) in HCV Liver Parenchymal changes legitimize Screening for SNPs before DAAs Therapy MDA Abd Alla, RM Dawood, HAELH Rashed, YM El-Dessouky, ... | 1 | 2021 |
| HCV treatment outcome depends on SNPs of IFNL3-Gene polymorphisms (rs12979860) and cirrhotic changes in liver parenchyma MDA Abd Alla, RM Dawood, HAELH Rashed, YM El-Dessouky, ... Heliyon 9 (11), 2023 | | 2023 |
| ASSESSMENT OF LIVER FIBROSIS BEFORE AND AFTER DIRECT ACTING ANTIVIRAL THERAPY IN COMPENSATED HCV RELATED LIVER DISEASE A Fathalla Khattab, I Ammar, A Mohamed Massoud Al-Azhar Medical Journal 50 (4), 2927-2936, 2021 | | 2021 |
| Treatment of hepatitis C virus infection with direct-acting antivirals plus ribavirin eliminates viral RNA from peripheral blood mononuclear cells and reduces virologic relapse … MDAA Alla, RM Dawood, HA El-Hafeth Rashed, G Farrag, IAE Ammar, ... | | 2021 |
